Alimera Sciences Profit Margin

The latest profit margin for ALIM is -14.74% as of June 2024. That compares with -46.61% in the prior-year period — up 68.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Alimera Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, ALIM's profit margin moved from -46.61% to -14.74% — a 68.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Alimera Sciences's valuation or profitability profile.

Against Healthcare companies, ALIM currently prints -14.74% for profit margin, while the sector average sits near 13.89%. That is roughly 206.1% below the sector mean. Large gaps often invite a closer look at Alimera Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Alimera Sciences converts resources into returns. At -14.74%, ALIM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -46.61% in the prior-year period — up 68.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ALIM's profit margin (-14.74%), review year-over-year change from -46.61%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.